Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Appl Neuropsychol Adult. 2017 Aug 29;26(1):17–27. doi: 10.1080/23279095.2017.1353993

Table 2.

Raw scores on primary CVLT-II variables across the study samples.

CVLT-II variable Healthy
(n=45)
HAND
(n=77)
TLE
(n=21)
HD
(n=47)d
Pairwise Comparisons Effect Size Effect Size Effect Size
a b c d a vs b b vs c b vs d
Total Trials 1–5 55.1 (9.8) 43.4 (9.9) 43.6 (11.5) 33.9 (12.7) a>b,c>d −1.2 −0.02 0.83
Short-delay free recall 11.8 (3.4) 8.1 (3.2) 8.1 (4.3) 5.8 (3.7) a>b,c.d; b>d −1.1 0.00 0.66
Short-delay cued recall 12.5 (3.4) 9.7 (3.0) 8.9 (3.5) 7.3 (3.9) a>b,c,d; b>d −0.87 0.25 0.69
Long-delay free recall 11.9 (3.4) 8.5 (3.4) 7.7 (4.3) 5.9 (3.7) a>b,c,d; b>d −1.0 0.22 0.73
Long-delay cued recall 12.6 (3.4) 9.7 (3.1) 8.6 (4.2) 6.9 (3.8) a>b,c,d; b>d −0.89 0.32 0.81
Total recognition discrim. 3.2 (0.8) 2.7 (0.8) 2.6 (1.1) 1.8 (0.9) a>b,c>d −0.63 0.11 1.06

Note. All omnibus p-values < .001. Pairwise comparisons based off Tukey-Kramer HSD tests, p < .05. CVLT-II = California Verbal Learning Test – Second Edition. Discrim = discriminability. HAND = HIV-Associated Neurocognitive Disorder. TLE = temporal lobe epilepsy. HD = Huntington’s disease. Effect sizes represent unadjusted Hedges g values, comparing the HAND group to the other three study groups.